vs
Side-by-side financial comparison of Bridgeline Digital, Inc. (BLIN) and CITIUS ONCOLOGY, INC. (CTOR). Click either name above to swap in a different company.
CITIUS ONCOLOGY, INC. is the larger business by last-quarter revenue ($3.9M vs $3.9M, roughly 1.0× Bridgeline Digital, Inc.). Bridgeline Digital, Inc. runs the higher net margin — -2.2% vs -140.3%, a 138.1% gap on every dollar of revenue.
Bridgeline Digital, Inc. provides digital experience solutions including web content management, e-commerce platforms, marketing automation tools, and custom digital development services. It primarily serves small and medium-sized North American enterprises across retail, healthcare, education, and non-profit segments.
Citius Oncology, Inc. is a late-stage biopharmaceutical company focused on developing innovative targeted therapies for cancer patients. Its core pipeline covers treatments addressing unmet medical needs in hematologic malignancies and solid tumors, primarily serving North American and global oncology care markets.
BLIN vs CTOR — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $3.9M | $3.9M |
| Net Profit | $-86.0K | $-5.5M |
| Gross Margin | 66.1% | 80.0% |
| Operating Margin | -4.4% | -133.2% |
| Net Margin | -2.2% | -140.3% |
| Revenue YoY | 3.2% | — |
| Net Profit YoY | 86.4% | 16.9% |
| EPS (diluted) | $-0.01 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.9M | $3.9M | ||
| Q3 25 | $3.9M | — | ||
| Q2 25 | $3.8M | — | ||
| Q1 25 | $3.9M | — | ||
| Q4 24 | $3.8M | — | ||
| Q3 24 | $3.9M | — | ||
| Q2 24 | $3.9M | — | ||
| Q1 24 | $3.8M | — |
| Q4 25 | $-86.0K | $-5.5M | ||
| Q3 25 | $-365.0K | — | ||
| Q2 25 | $-789.0K | — | ||
| Q1 25 | $-730.0K | — | ||
| Q4 24 | $-634.0K | — | ||
| Q3 24 | $-432.0K | — | ||
| Q2 24 | $-305.0K | — | ||
| Q1 24 | $-602.0K | — |
| Q4 25 | 66.1% | 80.0% | ||
| Q3 25 | 65.7% | — | ||
| Q2 25 | 66.3% | — | ||
| Q1 25 | 67.5% | — | ||
| Q4 24 | 66.9% | — | ||
| Q3 24 | 68.7% | — | ||
| Q2 24 | 68.8% | — | ||
| Q1 24 | 66.4% | — |
| Q4 25 | -4.4% | -133.2% | ||
| Q3 25 | -12.5% | — | ||
| Q2 25 | -17.9% | — | ||
| Q1 25 | -19.2% | — | ||
| Q4 24 | -13.5% | — | ||
| Q3 24 | -12.5% | — | ||
| Q2 24 | -9.7% | — | ||
| Q1 24 | -13.6% | — |
| Q4 25 | -2.2% | -140.3% | ||
| Q3 25 | -9.4% | — | ||
| Q2 25 | -20.5% | — | ||
| Q1 25 | -18.8% | — | ||
| Q4 24 | -16.7% | — | ||
| Q3 24 | -11.2% | — | ||
| Q2 24 | -7.7% | — | ||
| Q1 24 | -15.8% | — |
| Q4 25 | $-0.01 | $-0.06 | ||
| Q3 25 | $-0.02 | — | ||
| Q2 25 | $-0.07 | — | ||
| Q1 25 | $-0.10 | — | ||
| Q4 24 | $-0.06 | — | ||
| Q3 24 | $-0.04 | — | ||
| Q2 24 | $-0.03 | — | ||
| Q1 24 | $-0.06 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.5M | $7.3M |
| Total DebtLower is stronger | $236.0K | — |
| Stockholders' EquityBook value | $9.6M | $58.4M |
| Total Assets | $15.7M | $110.0M |
| Debt / EquityLower = less leverage | 0.02× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.5M | $7.3M | ||
| Q3 25 | $1.6M | — | ||
| Q2 25 | $2.1M | — | ||
| Q1 25 | $2.8M | — | ||
| Q4 24 | $1.5M | — | ||
| Q3 24 | $1.4M | — | ||
| Q2 24 | $1.2M | — | ||
| Q1 24 | $1.3M | — |
| Q4 25 | $236.0K | — | ||
| Q3 25 | $326.0K | — | ||
| Q2 25 | $348.0K | — | ||
| Q1 25 | $406.0K | — | ||
| Q4 24 | $409.0K | — | ||
| Q3 24 | $500.0K | — | ||
| Q2 24 | $524.0K | — | ||
| Q1 24 | $612.0K | — |
| Q4 25 | $9.6M | $58.4M | ||
| Q3 25 | $9.6M | — | ||
| Q2 25 | $9.9M | — | ||
| Q1 25 | $10.6M | — | ||
| Q4 24 | $9.6M | — | ||
| Q3 24 | $10.0M | — | ||
| Q2 24 | $10.3M | — | ||
| Q1 24 | $10.5M | — |
| Q4 25 | $15.7M | $110.0M | ||
| Q3 25 | $15.3M | — | ||
| Q2 25 | $16.1M | — | ||
| Q1 25 | $17.0M | — | ||
| Q4 24 | $15.5M | — | ||
| Q3 24 | $15.6M | — | ||
| Q2 24 | $16.0M | — | ||
| Q1 24 | $16.3M | — |
| Q4 25 | 0.02× | — | ||
| Q3 25 | 0.03× | — | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.04× | — | ||
| Q4 24 | 0.04× | — | ||
| Q3 24 | 0.05× | — | ||
| Q2 24 | 0.05× | — | ||
| Q1 24 | 0.06× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-39.0K | $-7.4M |
| Free Cash FlowOCF − Capex | $-46.0K | — |
| FCF MarginFCF / Revenue | -1.2% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-1.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-39.0K | $-7.4M | ||
| Q3 25 | $-345.0K | — | ||
| Q2 25 | $-565.0K | — | ||
| Q1 25 | $-372.0K | — | ||
| Q4 24 | $178.0K | — | ||
| Q3 24 | $217.0K | — | ||
| Q2 24 | $0 | — | ||
| Q1 24 | $-86.0K | — |
| Q4 25 | $-46.0K | — | ||
| Q3 25 | $-351.0K | — | ||
| Q2 25 | $-570.0K | — | ||
| Q1 25 | $-374.0K | — | ||
| Q4 24 | $173.0K | — | ||
| Q3 24 | $212.0K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-91.0K | — |
| Q4 25 | -1.2% | — | ||
| Q3 25 | -9.1% | — | ||
| Q2 25 | -14.8% | — | ||
| Q1 25 | -9.7% | — | ||
| Q4 24 | 4.6% | — | ||
| Q3 24 | 5.5% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -2.4% | — |
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.5% | — | ||
| Q1 24 | 0.1% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLIN
| Subscription | $3.2M | 81% |
| Other | $758.0K | 19% |
CTOR
Segment breakdown not available.
